SULLIVAN GREGORY M (Chief Medical Officer) received a stock award from TONIX PHARMACEUTICALS HOLDING CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/25/2021ACC: 0001387131-21-002884
Officer· Chief Medical Officer
Since Feb 2026
+1.54M
Net shares
Net buyer
$21.1K
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
1.54M acquired
Non-Derivative Transactions1
Common Stock, $0.001 par value
Direct
Shares
+41.32K
Price / share
$0.51
Trade value
$21.07K
% of position
193.0%
1/7/2021
21.41K→62.73K
Total
Net shares
+41.32K
Net value
$21.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value Direct | 1/7/2021 | A · Award | +41.32K | $0.51 | $21.07K | 193.0% | 21.41K | 62.73K |
| Total | +41.32K | $21.07K | ||||||
Derivative Transactions2
Stock Option
Direct
Converts to
Common Stock
750K shares
Shares
+750K
Strike price
1.22
Held after
750K
Exercisable
—
2/23/2021
Stock Option
Direct
Converts to
Common Stock
750K shares
Shares
+750K
Strike price
1.53
Held after
750K
Exercisable
—
2/23/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock750K shares | 2/23/2021 | A · Award | +750K | 1.22 | — | 750K |
| Stock Option Direct | Common Stock750K shares | 2/23/2021 | A · Award | +750K | 1.53 | — | 750K |